Beihai Gofar Marine Biological Industry Co Ltd (600538) - Total Assets
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) holds total assets worth CN¥964.41 Million CNY (≈ $141.12 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 600538 book value for net asset value and shareholders' equity analysis.
Beihai Gofar Marine Biological Industry Co Ltd - Total Assets Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's total assets have evolved over time, based on quarterly financial data.
Beihai Gofar Marine Biological Industry Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beihai Gofar Marine Biological Industry Co Ltd's total assets of CN¥964.41 Million consist of 50.8% current assets and 49.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.0% |
| Accounts Receivable | CN¥256.23 Million | 26.5% |
| Inventory | CN¥82.94 Million | 8.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥27.29 Million | 2.8% |
| Goodwill | CN¥138.46 Million | 14.3% |
Asset Composition Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Beihai Gofar Marine Biological Industry .
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beihai Gofar Marine Biological Industry Co Ltd's current assets represent 50.8% of total assets in 2024, an increase from 41.7% in 1999.
- Cash Position: Cash and equivalents constituted 15.0% of total assets in 2024, up from 7.6% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 7.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 26.5% of total assets.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Total Assets
Key competitors of Beihai Gofar Marine Biological Industry Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fanli Digital Technology Co Ltd
SHG:600228
|
China | CN¥575.15 Million |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
CF Industries Holdings Inc
NYSE:CF
|
USA | $14.20 Billion |
|
Sumitomo Chemical India Limited
NSE:SUMICHEM
|
India | Rs44.39 Billion |
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
Nufarm Ltd
AU:NUF
|
Australia | AU$4.58 Billion |
|
Madhya Bharat Agro Products Limited
NSE:MBAPL
|
India | Rs12.07 Billion |
|
Itafos Corp
V:IFOS
|
Canada | CA$838.04 Million |
Beihai Gofar Marine Biological Industry Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.02 | 3.61 | 2.38 |
| Quick Ratio | 3.28 | 3.01 | 2.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥378.44 Million | CN¥361.35 Million | CN¥294.16 Million |
Beihai Gofar Marine Biological Industry Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beihai Gofar Marine Biological Industry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.37 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | CN¥966.75 Million |
| Market Capitalization | $515.47 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beihai Gofar Marine Biological Industry Co Ltd's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Beihai Gofar Marine Biological Industry Co Ltd's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Beihai Gofar Marine Biological Industry Co Ltd (1999–2024)
The table below shows the annual total assets of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥966.75 Million ≈ $141.47 Million |
-8.41% |
| 2023-12-31 | CN¥1.06 Billion ≈ $154.46 Million |
-7.58% |
| 2022-12-31 | CN¥1.14 Billion ≈ $167.13 Million |
+5.48% |
| 2021-12-31 | CN¥1.08 Billion ≈ $158.44 Million |
+1.60% |
| 2020-12-31 | CN¥1.07 Billion ≈ $155.95 Million |
+42.09% |
| 2019-12-31 | CN¥750.05 Million ≈ $109.76 Million |
-1.75% |
| 2018-12-31 | CN¥763.38 Million ≈ $111.71 Million |
-1.72% |
| 2017-12-31 | CN¥776.75 Million ≈ $113.66 Million |
-18.90% |
| 2016-12-31 | CN¥957.71 Million ≈ $140.14 Million |
-2.67% |
| 2015-12-31 | CN¥984.02 Million ≈ $143.99 Million |
-0.72% |
| 2014-12-31 | CN¥991.16 Million ≈ $145.04 Million |
+43.49% |
| 2013-12-31 | CN¥690.74 Million ≈ $101.08 Million |
+12.50% |
| 2012-12-31 | CN¥613.98 Million ≈ $89.84 Million |
-11.85% |
| 2011-12-31 | CN¥696.54 Million ≈ $101.93 Million |
-1.45% |
| 2010-12-31 | CN¥706.76 Million ≈ $103.42 Million |
-25.09% |
| 2009-12-31 | CN¥943.42 Million ≈ $138.05 Million |
-21.85% |
| 2008-12-31 | CN¥1.21 Billion ≈ $176.65 Million |
-7.72% |
| 2007-12-31 | CN¥1.31 Billion ≈ $191.43 Million |
+0.54% |
| 2006-12-31 | CN¥1.30 Billion ≈ $190.39 Million |
+2.64% |
| 2005-12-31 | CN¥1.27 Billion ≈ $185.50 Million |
+21.28% |
| 2004-12-31 | CN¥1.05 Billion ≈ $152.94 Million |
+41.20% |
| 2003-12-31 | CN¥740.21 Million ≈ $108.32 Million |
+214.69% |
| 2002-12-31 | CN¥235.22 Million ≈ $34.42 Million |
+13.82% |
| 2001-12-31 | CN¥206.66 Million ≈ $30.24 Million |
+5.45% |
| 2000-12-31 | CN¥195.98 Million ≈ $28.68 Million |
+17.39% |
| 1999-12-31 | CN¥166.95 Million ≈ $24.43 Million |
-- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more